Tune Therapeutics

Tune Therapeutics is a biotechnology company pioneering the creation of epigenetic editing therapies, also known as genetic tuning. They have developed a proprietary platform called TEMPO that allows them to precisely and durably change gene expression without permanently altering the DNA sequence. This approach opens up a new frontier in genetic medicine, addressing a wide range of common and complex diseases for which existing treatments are inadequate.

Tune is built upon a foundation of cutting-edge research and a team of experts in gene and cell therapy, genome editing, and epigenetics. They have secured foundational intellectual property from Duke University and secured significant funding from leading investors, allowing them to rapidly advance preclinical research and develop their therapeutic platform. Tune has offices in Durham, NC and Seattle, WA, drawing upon deep local talent pools to build their discovery and development teams.

Tune Therapeutics offers flexible work arrangements, including remote work opportunities, and provides stipends for parking and public transportation services in Seattle. They also offer a monthly stipend for phone bills or home office supplies, enabling employees to work effectively from various locations.

Tune Therapeutics offers a comprehensive benefits package designed to support employees' health, financial security, and well-being. This includes comprehensive medical, dental, and vision insurance, life and accidental death and dismemberment insurance, long-term disability coverage, and parental leave for both primary and secondary caregivers. Employees can also participate in a 401k retirement savings plan and receive stipends for Seattle parking, public transportation, phone bills, and home office supplies.

Tune Therapeutics is a biotechnology company pioneering the creation of epigenetic editing therapies, aiming to revolutionize genetic medicine by addressing complex, pervasive diseases that have long eluded treatment. Their innovative TEMPO platform leverages the power of the epigenome, fine-tuning gene networks without altering DNA sequences, to unlock the full potential of regenerative medicine and create solutions for even the most challenging and intractable diseases.

Tune Therapeutics cultivates a vibrant and diverse culture that values collaboration, innovation, and a shared commitment to transforming human health. The company prioritizes an ego-less environment where individual contributions are celebrated, and the pursuit of groundbreaking solutions is encouraged.

Tune Therapeutics is committed to fostering a diverse and inclusive workplace where everyone feels valued and accepted. They believe that diverse perspectives and backgrounds enhance the work they do, and they are proud to be an equal opportunity employer committed to fair hiring practices regardless of race, color, gender identity or expression, physical or mental disability, age, religion, national origin, ancestry, sexual orientation, marital status, or veteran status. They offer comprehensive benefits and strive to create a community where everyone can thrive.